Internal Medicine, Rheumatology · Glastonbury, CT
NPI
1386625432
Since 2005
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
2
Medicare group memberships
Hospitals
3
Hospital affiliations
195 Eastern Blvd, # 201
Glastonbury, CT, 06033
Phone (860) 246-4260
Groups this clinician bills Medicare through
Medicare paid, 2024
$747K
61,190 services
Medicare patients, 2024
314
Average age 76
Drug cost, 2024
$2.2M
3,947 prescriptions
Company payments, 2025
$5,867
From 29 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Christopher J Scola was code J1602 (injection, golimumab, 1 mg, for intravenous use), 12,050 times for 17 patients. In total Christopher J Scola billed 61,190 services in 57 codes, and Medicare paid $747K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-07-29.
| Code |
|---|
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1602 Injection, golimumab, 1 mg, for intravenous use | Office | 12,050 | 17 | $9.04 | $109K |
| J1010 Injection, methylprednisolone acetate, 1 mg | Office | 4,281 | 52 | $0.10 | $434 |
| J9312 Injection, rituximab, 10 mg | Office | 4,250 | 17 | $61.34 | $261K |
| J0897 Injection, denosumab, 1 mg | Office | 1,741 | 18 | $20.45 | $36K |
| J2919 Injection, methylprednisolone sodium succinate, 5 mg | Office | 974 | 18 | $0.23 | $220 |
| 99214 Office E&M - Established | Office | 461 | 238 | $104.73 | $48K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 206 | 158 | $14.06 | $2,897 |
| 96413 Chemotherapy Administration | Office | 199 | 54 | $116.66 | $23K |
| 96415 Chemotherapy Administration | Office | 141 | 23 | $24.90 | $3,511 |
| 96401 Chemotherapy Administration | Office | 115 | 29 | $64.90 | $7,463 |
| 99213 Office E&M - Established | Office | 88 | 75 | $63.64 | $5,600 |
| 20611 Joint Injection | Office | 71 | 42 | $85.34 | $6,059 |
| 76881 Ultrasound - Nonspecific | Office | 52 | 43 | $43.35 | $2,254 |
| 96375 Injection Administration | Office | 40 | 18 | $13.81 | $552 |
| J1040 Injection, methylprednisolone acetate, 80 mg | Office | 25 | 21 | $6.76 | $169 |
By year: 2022 $733K for 59,766 services; 2023 $609K for 59,386 services; 2024 $747K for 61,190 services.
Medicare prescription drug claims, 2024
In 2024, the drug Christopher J Scola prescribed most often to Medicare patients was Hydroxychloroquine Sulfate, with 785 prescriptions and refills. In total Christopher J Scola wrote 3,947 Medicare prescriptions that cost $2.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydroxychloroquine Sulfate Generic | 785 | 1,549 | 202 | $25K |
| Prednisone Generic | 669 | 1,134 | 184 | $4,930 |
| Methotrexate Methotrexate Sodium | 417 | 908 | 98 | $8,697 |
| Leucovorin Calcium Generic | 218 | 474 | 56 | $2,130 |
| Duloxetine Hcl Generic | 200 | 470 | 50 | $4,224 |
| Tramadol Hcl Generic | 191 | 204 | 42 | $1,341 |
| Gabapentin Generic | 171 | 294 | 45 | $3,276 |
| Allopurinol Generic | 120 | 343 | 39 | $1,863 |
| Cyclobenzaprine Hcl Generic | 77 | 85 | 20 | $618 |
| Methylprednisolone Generic | 71 | 93 | 33 | $892 |
| Enbrel Sureclick Etanercept | 70 | 81 | Under 11 | $611K |
| Amitriptyline Hcl Generic | 64 | 96 | 13 | $621 |
| Alendronate Sodium Generic | 56 | 133 | 15 | $556 |
| Tramadol Hcl-Acetaminophen Tramadol Hcl/Acetaminophen | 56 | 67 | Under 11 | $854 |
| Celecoxib Generic | 54 | 111 | 16 | $807 |
Brand drugs: - claims; generic drugs: 3,628 claims; opioid claims: 340.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Christopher J Scola $5,867 ($5,867 in general payments such as food, travel and fees) from 29 companies. The largest payer was Abbvie Inc. with $1,086.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 64 | $1,086 |
| Amgen Inc. AMGN | 35 | $833 |
| Janssen Biotech, Inc. JNJ | 37 | $635 |
| UCB, Inc. UCB.BR | 37 | $594 |
| Mallinckrodt Hospital Products Inc. | 17 | $337 |
| ANI Pharmaceuticals, Inc. ANIP | 16 | $288 |
| Novartis Pharmaceuticals Corporation NVS | 13 | $277 |
| E.R. Squibb & Sons, L.L.C. BMY | 12 | $235 |
| AstraZeneca Pharmaceuticals LP AZN | 8 | $183 |
| Lilly USA, LLC LLY | 7 | $169 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.